The transcriptomic profiling of lung damage associated with SARS-CoV-2 infection may lead to the development of effective therapies to prevent COVID-19-related deaths. We selected a series of 21 autoptic lung samples, 14 of which had positive nasopharyngeal swabs for SARS-CoV-2 and a clinical diagnosis of COVID-19-related death; their pulmonary viral load was quantified with a specific probe for SARS-CoV-2. The remaining seven cases had no documented respiratory disease and were used as controls. RNA from formalin-fixed paraffin-embedded (FFPE) tissue samples was extracted to perform gene expression profiling by means of targeted (Nanostring) and comprehensive RNA-Seq. Two differential expression designs were carried out leading to relevant results in terms of deregulation. SARS-CoV-2 positive specimens presented a significant overexpression in genes of the type I interferon signaling pathway (IFIT1, OAS1, ISG15 and RSAD2), complement activation (C2 and CFB), macrophage polarization (PKM, SIGLEC1, CD163 and MS4A4A) and Cathepsin C (CTSC). CD163, Siglec-1 and Cathepsin C overexpression was validated by immunohistochemistry. SFTPC, the encoding gene for pulmonary-associated surfactant protein C, emerged as a key identifier of COVID-19 patients with high viral load. This study successfully recognized SARS-CoV-2 specific immune signatures in lung samples and highlighted new potential therapeutic targets. A better understanding of the immunopathogenic mechanisms of SARS-CoV-2 induced lung damage is required to develop effective individualized pharmacological strategies.
Motivation: Recent advances in DNA and RNA sequencing technologies and the gradual decrease in costs have allowed to design serial experiments with timestamps, even at single cell resolution. This possibility unlocks a finer level of detail, as well as a huge amount of noisy information to decode. Tools inferring regulatory networks, or patterns, from this type of data often focus on trajectories, disregarding local shapes and fundamental time series primitives. Moreover, they fail to target the analysis on a few meaningful results, reporting large and noisy outputs that need further downstream analysis. Results: We describe SHISMA, a novel tool to infer significant cell type-specific co-dynamic gene subnetworks, from time series transcriptomic data, with strong statistical guarantees in terms of P value. SHISMA leverages isolated cell populations thanks to single-cell resolution, constructing cell type-specific pseudobulk time-series datasets. It then exploits a recently proposed time series primitive, the Bag-of-Receptive-Fields, adapted to discretize shorter temporal data and retain local shapes. SHISMA extracts significant groups of genes by performing a random walk approach on a protein–protein interaction network, with nodes identified by genes and scores derived from the shape-induced representation of the data, while properly validating via permutation and correcting for multiple hypothesis testing. Our extensive experimental evaluation on synthetic data shows that our tool is able to retrieve specific and significant subnetworks from time series transcriptomic data. Moreover, the subnetworks identified by SHISMA on real-world data confirm its ability to retrieve known cell type-specific processes, as well as potentially novel patterns and co-dynamic mechanisms. Availability and implementation: https://github.com/antoniocollesei/SHISMA